Serious Side Effects : In rare cases, GLP-1 injections can cause pancreatitis or gallbladder issues
Retatrutide hits 28% weight loss in Phase 3 A summary of the interesting content that I consumed this past week What I Read This Week: a summary of the content that I consumed this past week Caught My Eye 1) Retatrutide hits 28% weight loss in Phase 3 On May 21, Eli Lilly released Phase 3 results for retatrutide from the 2,339-patient TRIUMPH-1 obesity trial
Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, et al
330 mcg 10 units and 500 mcg 15 units on a U-100 syringe
Compounded semaglutide has also become widely available at some specialty pharmacies